Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapy

Neuro-Oncology(2024)10.1093/neuonc/noae105Source: DataRank Database

Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapy is a research paper published in Neuro-Oncology (2024). On theSindex it has a DataRank of 0.652. It has been cited 22 times, with 21 citing works in its 1-hop citation network.

N/A

0.652DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access22 citations · 21 citing works in its network

Download PDF

Cite:

Linked data & code

nct doi

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT03152318

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (18 grants)Impact (FWCI 8.83)OA: hybridTopics (82)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 72%Citation Network 28%

Base Score Contribution

0.470

From this paper's citation signal

Citation Network Contribution

0.181

From 12 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 21 citers.

A novel near-infrared fluorescent hERG potassium channel probe for glioblastoma therapy and imaging
Chemical Science20253 citations39 referencesContributes 0.036
Stereotactic radiosurgery treatment of pediatric arteriovenous malformations: a PRISMA systematic review and meta-analysis
Child s Nervous System20255 citations51 referencesContributes 0.035
HSV-1 as a gene delivery platform for cancer gene therapy
Trends in Pharmacological Sciences202517 citations89 referencesContributes 0.032
A feasibility trial of delayed resection for brain metastases following pre-operative stereotactic radiosurgery
Journal of Neuro-Oncology20252 citations37 referencesContributes 0.030
Subtypes of tumor-associated neutrophils and their roles in cancer immunotherapy
Critical Reviews in Oncology/Hematology20254 citations96 referencesContributes 0.017

Authors (20)

Jin Muk Kang ORCID,Alexandra Miller ORCID,Grace Nguyen ORCID,Minxin Huang,Ji Seon Shim ORCID

Live enrichment

PubMed:38853689 PMC:PMC11376453 OpenAlex:https://openalex.org/W4399501638

American Cancer Society

Grant: R21NS123685 and R01CA276942

National Institutes of Health

Grant: RP200615

NCI NIH HHS

Grant: R03 CA252770

NCI NIH HHS

Grant: R01 CA150153

NINDS NIH HHS

Grant: R21 NS123685

NINDS NIH HHS

Grant: R61NS112410

NCI NIH HHS

Grant: R01 CA276942

NINDS NIH HHS

Grant: R01 NS127473

NCI NIH HHS

Grant: R41CA247044

NCI NIH HHS

Grant: P01CA163205

NINDS NIH HHS

Grant: R61 NS128191

National Institutes of Health

Grant: 5R21NS123685-02

IGF1R-targeted oncolytic herpes simplex viral therapy for Glioblastoma

National Institutes of Health

Grant: 1R03CA252770-01A1

Simultaneous targeting of tumor cells and tumor associated macrophages by RNA nanovector

National Institutes of Health

Grant: 3P01CA163205-03S1

Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas

National Institutes of Health

Grant: 1R41CA247044-01

Oncolytic virus-mediated target delivery of a therapeutic antibody fragment in glioblastoma

National Institutes of Health

Grant: 5R61NS112410-02

Optimizing oncolytic virus therapy for glioblastoma

National Institutes of Health

Grant: 5R01CA150153-09

Enhancing viral oncolysis with vasculostatin gene delivery

National Institutes of Health

Grant: 5R01CA276942-03

Enhanced Viro-Immunotherapy for Breast Cancer Brain Metastasis

FWCI

8.83

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1093/neuonc/noae105

publisherhttps://doi.org/10.1093/neuonc/noae105

publisherhttps://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noae105/58789809/noae105.pdf

publisherhttps://academic.oup.com/neuro-oncology/article-pdf/26/9/1602/59028640/noae105.pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38853689

Fields of Study

Virus-based gene therapy researchGrowth Hormone and Insulin-like Growth FactorsHerpesvirus Infections and Treatments0301 basic medicine03 medical and health sciences0303 health sciencesAnimalsFemaleHumansMiceBrain NeoplasmsBreast NeoplasmsGlioblastomaGliomaHerpesvirus 1, HumanImmunotherapyInsulin-Like Growth Factor IIOncolytic VirotherapyOncolytic VirusesTumor Cells, CulturedTumor MicroenvironmentXenograft Model Antitumor Assays

MeSH Terms

AnimalsBrain NeoplasmsBreast NeoplasmsFemaleGlioblastomaGliomaHumansImmunotherapyInsulin-Like Growth Factor IITumor Cells, CulturedHerpesvirus 1, HumanXenograft Model Antitumor AssaysOncolytic VirotherapyOncolytic VirusesMiceTumor Microenvironment

Keywords

Tumor microenvironmentImmunotherapyCancer immunotherapyCancer researchComputational biologyChemistryBiologyTumor cellsImmune systemImmunologyGlioblastoma (Gbm)Insulin-like Growth Factor-1 Receptor (Igf1r)Insulin-like Growth Factor 2 (Igf2)Tumor Microenvironment (Tme)Oncolytic Herpes Simplex Virus-1 (Ohsv)Medical SciencesBioinformatics610DiseasesBreast NeoplasmsHerpesvirus 1, HumanBiomedical InformaticsMiceInsulin-Like Growth Factor IINeoplasmsMedical SpecialtiesMedicine and Health SciencesTumor Cells, CulturedAnimalsHumansOncolytic VirotherapyCulturedHerpesvirus 1Brain Neoplasms500GliomaXenograft Model Antitumor AssaysOncolytic VirusesNeurologyOncologyBasic and Translational InvestigationsFemaleGlioblastomaHuman

Sustainable Development Goals

SDG 0: Good health and well-being